Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;11(2):242-245.
doi: 10.1097/UPJ.0000000000000512. Epub 2023 Dec 28.

Preventing the 17-Year Gap in Overactive Bladder Prescribing Practices: The Need for Implementation Science

Michael B Chancellor  1
Affiliations

Preventing the 17-Year Gap in Overactive Bladder Prescribing Practices: The Need for Implementation Science

Michael B Chancellor. Urol Pract. 2024 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: M.B.C. is a consultant for Cook MyoSite and AMAG Pharmaceuticals and has other interests in Lipella Pharmaceuticals, Inc.

Comment in

  • Editorial Comment.
    Robinson LM, Williams TR, Tabakin AL. Robinson LM, et al. Urol Pract. 2024 Mar;11(2):244-245. doi: 10.1097/UPJ.0000000000000512.01. Epub 2023 Dec 28. Urol Pract. 2024. PMID: 38153024 No abstract available.

References

    1. Rubin R. It takes an average of 17 years for evidence to change practice-the burgeoning field of implementation science seeks to speed things up. JAMA. 2023;329(16):1333-1336. - PubMed
    1. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510-520. - PMC - PubMed
    1. Kilbourne AM, Glasgow RE, Chambers DA. What can implementation science do for you? Key success stories from the field. J Gen Intern Med. 2020;35(suppl 2):783-787. - PMC - PubMed
    1. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558-563. - PubMed
    1. Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D'Angelo K. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc. 1998;46(1):8-13. - PubMed

MeSH terms